Logo 2839 Logo 2839 (Fenofibric Acid Delayed-Release 135 mg)
Pill with imprint Logo 2839 Logo 2839 is Brown & Yellow, Capsule-shape and has been identified as Fenofibric Acid Delayed-Release 135 mg. It is supplied by Actavis Pharma, Inc..
Fenofibric acid is used in the treatment of high cholesterol; hypertriglyceridemia and belongs to the drug class fibric acid derivatives. Risk cannot be ruled out during pregnancy. Fenofibric acid 135 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for Logo 2839 Logo 2839
Fenofibric Acid Delayed-Release
- Imprint:
- Logo 2839 Logo 2839
- Strength:
- 135 mg
- Color:
- Brown & Yellow
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Fibric acid derivatives
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Actavis Pharma, Inc.
- National Drug Code (NDC):
- 00228-2839
More about fenofibric acid
- Fenofibric acid Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 24 Reviews
- Drug class: fibric acid derivatives
Consumer resources
Other brands: Trilipix, Fibricor
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
